Management of chronic ischemic heart disease into internal medicine and geriatric departments in Italy

A Correction to this article is available

This article has been updated

This is a preview of subscription content, log in to check access.

Change history

  • 28 February 2020

    In the original publication of the article


  1. 1.

    National Institutes of Health NH, Lung, and Blood Institute. Morbidity and mortality: 2012 chart book on cardiovascular, lung, and blood diseases. Bethesda, MD: National Heart, Lung, and Blood Institute: 2012.

  2. 2.

    Daly CA, De Stavola B, Sendon JL et al (2006) Predicting prognosis in stable angina: results from the Euro heart survey of stable angina: prospective observational study. BMJ 332:262–267

    Article  Google Scholar 

  3. 3.

    Arnold SV, Jang JS, Tang F et al (2015) Prediction of residual angina after percutaneous coronary intervention. Eur Heart J 1:23–30

    Google Scholar 

  4. 4.

    Perk J, De Backer G, Gohlke H et al (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur Heart J 33:1635–1701

    CAS  Article  Google Scholar 

  5. 5.

    Commissione ANMCO/GICR-IACPR/GISE, Greco C, Bovenzi FM, Berti S et al (2014) Documento ANMCO/GICR-IACPR/GISE—L’organizzazione dell’assistenza nella fase post-acuta delle sindromi coronariche. G Ital Cardiol 15(Suppl 1):3S–27S

    Google Scholar 

  6. 6.

    Cannon CP, Harrington RA, James S et al (2010) Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndrome (PLATO): a ranomised double-blind study. Lancet 375:283–293

    CAS  Article  Google Scholar 

  7. 7.

    Yusuf S, Wittes J, Friedman L (1988) Overview of results of randomized clinical trials in heart disease. Treatments following myocardial infarction. JAMA 260:2088–2093

    CAS  Article  Google Scholar 

  8. 8.

    Jerling M (2006) Clinical pharmacokinetics of ranolazine. Clin Pharmacokinet 45:469–491

    CAS  Article  Google Scholar 

  9. 9.

    Timmis AD, Chaitman BR, Crager M (2006) Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes. Eur Heart J 27:42–48

    CAS  Article  Google Scholar 

  10. 10.

    Morrow DA, Scirica BM, Chaitman BR et al (2009) Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial. Circulation 119:2032–2039

    CAS  Article  Google Scholar 

  11. 11.

    Rayner-Hartley E, Parvand M, Humphries KH et al (2018) Ranolazine for symptomatic management of microvascular angina. Am J Ther.

    Article  PubMed  Google Scholar 

  12. 12.

    Safdar B, D’Onofrio G, Dziura J et al (2017) Ranolazine and microvascular angina by PET in the Emergency Department: results from a pilot randomized controlled trial. Clin Ther 39:55–63

    CAS  Article  Google Scholar 

  13. 13.

    Califf RM, Mark DB, Harrell FE Jr et al (1988) Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. J Am Coll Cardiol 11:20–26

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Francesco Perticone.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Perticone, F., Fontanella, A., Ferrara, N. et al. Management of chronic ischemic heart disease into internal medicine and geriatric departments in Italy. Intern Emerg Med 15, 151–154 (2020).

Download citation